Work on an imaging test to detect and monitor inflammation in brain tumours will take a step forward thanks to two new grants. Researchers within our brain imaging theme are developing a clinically applicable imaging test that could be used in all magnetic resonance imaging (MRI) scanners to help predict tumour growth and guide treatment.
Scientists from our brain tumour theme along with colleagues from the Manchester Centre for Clinical Neurosciences, part of Northern Care Alliance NHS Foundation Trust have published a paper in Neuro-Oncology Advances. It is the first in vivo evidence of increased TSPO expression and inflammation within the brains of patients with growing sporadic vestibular schwannomas.
Manchester is one of nine leading universities which will benefit from a record £35 million funding injection from the British Heart Foundation (BHF) to help strengthen world-leading cardiovascular disease research in the UK. The funding comes from the highly competitive Research Excellence Awards funding scheme.
A team of researchers from The University of Manchester and the Geoffrey Jefferson Brain Research Centre have made an exciting discovery. This important research has been published in the prestigious journal Science Advances and could pave the way for new treatments in the future.
The Natalie Kate Moss Trust (NKMT) was set up in 2012 by the Moss family, following the sudden death of Natalie at the age of 26 after an unexpected brain haemorrhage.Focusing on turning this tragedy into something positive, their mission is to empower more people to...
Dementia theme lead Dr Ross Dunne will be overseeing the research team at the Dementia Research Centre and the brainHealth Manchester clinic in the Dementias Platform UK (DPUK) blood biomarker challenge, a project which aims to bring cutting-edge blood tests for diagnosing dementia within the NHS.
NF2-Related Schwannomatosis is a rare genetic condition affecting 1 in 33,000. Despite its impact, it remains lesser known. Our latest podcast episode shines a light on NF2, making the complex understandable.
The North American Skull Base Society meeting took place in Atlanta from 16-18 February. It was a fantastic forum for learning & discussion across the whole breadth of skull base surgery. Colleagues from the Jeff attended to give invited talks at the meeting.
The team aims to bring this cutting-edge technology to preclinical stroke research to gain a better understanding of the mechanisms of SD initiation and their involvement in worsening stroke severity. This work will be a crucial first step in the maturity of this technology towards future clinical translation where they anticipate that it will greatly facilitate management of patients in the neuro-intensive care units.
Pneumonia affects around 1 in 12 people after a stroke and increases their chances of death and disability. CHOSEN aimed to determine the feasibility of different oral healthcare treatments, supported by staff education and training, to prevent pneumonia in UK stroke unit care.
Geoffrey Jefferson Brain Research Centre
Clinical Sciences Building
Northern Care Alliance
NHS Foundation Trust
Salford
M6 8FJ
Email: GJBRC@manchester.ac.uk
Recent Comments